Affordable Care Act Is Helping Young Americans With Cancer Beat the Disease
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Oct. 9, 2024 -- Cancer in young adults is rare, but the insurance coverage given them by the Affordable Care Act (ACA) has greatly boosted the survival of people ages 19 to 25 who got the disease, a new study shows.
The findings were published Oct. 7 in the journal Cancer.
The ACA (also known as Obamacare) passed Congress in 2010 and allowed people in that age group to remain covered by their parents' plans.
How did that affect their cancer outcomes?
To find out, researchers at Oregon Health & Science University (OHSU) tracked cancer death data from the U.S. Centers for Disease Control and Prevention and another major federal database for the years 2010 through 2021.
They compared death rates for the newly covered age group of 19-25 to that of younger (12 to 18) and older people (26 to 32).
They found that the 19 to 25 age group "was the only age group of the three to have had improvements in both cancer survival and death rate trends after ACA implementation," according to a journal news release.
The results were dramatic: Following the passage of the ACA, people ages 19 through 25 had a 6-year cancer survival rate that was 2.6 times higher than that of 12-to-18-year-olds, and 3.9 times greater than people ages 26 to 32.
In terms of the number of cancer deaths, people ages 19 to 25 saw decreases that were more than 2.1 and 1.5 times greater than people in the younger and older age groups, respectively, the study also found.
Study lead author Dr. Archie Bleyer called that a success.
Within a decade of its passage, the ACA's extended coverage for youth "allowed young adults with cancer who were covered by it to live longer and more likely be cured," he said.
The initiative and Medicaid "should not only be continued but expanded to enable more Americans to be diagnosed earlier, require less therapy, and, for those diagnosed later with their disease, to live longer and have higher cure rates,” said Bleyer, who is health services research collaborator of cancer medicine at OHSU's Knight Cancer Institute.
Young patients with other conditions have also likely benefited, Bleyer added.
“Other serious physical or mental diseases are likely also having better outcomes" among young adults, he said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-10 06:00
Read more
- Blood Pressure Ups & Downs May Harm Seniors' Thinking
- Planned Home Births Are Safe for Low-Risk Pregnancies
- Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds
- Need Some 'Alone Time'? It's Vital to Mental Health for Many
- FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity
- Poststroke Epilepsy Risk Varies With Antihypertensive Treatment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions